Ethic Inc. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 107,811 shares of the healthcare conglomerate's stock after buying an additional 2,948 shares during the period. UnitedHealth Group comprises 0.4% of Ethic Inc.'s portfolio, making the stock its 28th largest holding. Ethic Inc.'s holdings in UnitedHealth Group were worth $39,575,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. StoneX Group Inc. lifted its holdings in shares of UnitedHealth Group by 36.5% during the 3rd quarter. StoneX Group Inc. now owns 3,632 shares of the healthcare conglomerate's stock worth $1,350,000 after acquiring an additional 971 shares during the period. Verus Capital Partners LLC bought a new stake in UnitedHealth Group in the third quarter valued at about $598,000. Keyes Stange & Wooten Wealth Management LLC raised its position in UnitedHealth Group by 24.8% in the third quarter. Keyes Stange & Wooten Wealth Management LLC now owns 1,237 shares of the healthcare conglomerate's stock worth $454,000 after purchasing an additional 246 shares in the last quarter. LightSquare Wealth Management LLC raised its position in UnitedHealth Group by 16.2% in the third quarter. LightSquare Wealth Management LLC now owns 638 shares of the healthcare conglomerate's stock worth $234,000 after purchasing an additional 89 shares in the last quarter. Finally, Kingstone Capital Partners Texas LLC lifted its stake in UnitedHealth Group by 1.1% during the third quarter. Kingstone Capital Partners Texas LLC now owns 15,023 shares of the healthcare conglomerate's stock worth $5,515,000 after purchasing an additional 163 shares during the period. Institutional investors own 87.86% of the company's stock.
Insider Transactions at UnitedHealth Group
In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.19% of the stock is currently owned by corporate insiders.
Key Stories Impacting UnitedHealth Group
Here are the key news stories impacting UnitedHealth Group this week:
UnitedHealth Group Stock Performance
UNH stock opened at $394.14 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The company has a 50 day moving average price of $390.62 and a 200 day moving average price of $364.03. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The stock has a market capitalization of $353.16 billion, a PE ratio of 22.51, a price-to-earnings-growth ratio of 1.43 and a beta of 0.51.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. The firm had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business's quarterly revenue was down .4% compared to the same quarter last year. During the same period last year, the company earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group's dividend payout ratio is 53.00%.
Wall Street Analyst Weigh In
UNH has been the topic of several analyst reports. Royal Bank Of Canada upped their price objective on UnitedHealth Group from $478.00 to $498.00 and gave the company an "outperform" rating in a research note on Tuesday, October 20th. JPMorgan Chase & Co. raised their target price on UnitedHealth Group from $516.00 to $524.00 and gave the stock an "overweight" rating in a research report on Friday, October 16th. Stephens set a $500.00 price target on UnitedHealth Group in a research report on Friday, October 16th. Mizuho increased their price objective on UnitedHealth Group from $493.00 to $500.00 and gave the stock an "outperform" rating in a research note on Thursday, October 22nd. Finally, Sanford C. Bernstein cut their price objective on UnitedHealth Group from $512.00 to $500.00 and set an "outperform" rating for the company in a report on Wednesday, October 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $463.93.
Get Our Latest Stock Report on UnitedHealth Group
About UnitedHealth Group
(
Free Report)
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.
Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.